https://www.selleckchem.com/pr....oducts/Cyclopamine.h
Of the 152 patients followed up for a median of 20 months (interquartile range limits, 16.5-32), median overall survival was 12.3 months (95% credible interval [95%CrI], 11.3-13.7), with a 1.12 [95%CrI, 0.67-1.83] age-adjusted hazard ratio between metastatic and non-metastatic MANEC. Stage IV disease at diagnosis was more prognostically unfavorable in cases of colonic compared to anorectal origin. MANEC is a clinically aggressive pathological entity. The results of this study provide new insights for the understanding of tumor locat
Like
Comment
Share
